Fortitude Invests $1M in HeartSciences at 22% Premium, Merger Terms Unchanged
HSCS sits 37% above its 52-week low of $1.63.
Summary
Fortitude Mining Holdings is investing $1.0 million in HeartSciences at a 22% premium to the current market price, with no adjustment to the merger consideration. This direct cash infusion from the merger partner signals confidence in the deal and provides near-term liquidity. Following the investment, Fortitude now holds about 9.4% of HeartSciences' outstanding shares of common stock. The premium price suggests Fortitude values HeartSciences above its current trading level, which could support the stock. The investment follows the definitive all-stock merger agreement announced in June and the recent 10-K that raised going concern warnings. The merger proxy is pending, and this investment may help address liquidity concerns ahead of the shareholder vote.
Updates
· Dow Jones Newswires — Fortitude reported Q2 revenue of $20.9 million and adjusted EBITDA of $8.5 million, mining 33,646 ZEC at a 4.0 GSol/s average hash rate. It purchased 411,522 HeartSciences shares on August 12 at $2.43 per share.
At the time of this announcement, HSCS was trading at $2.23 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $8.3M. The 52-week trading range was $1.63 to $3.93. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.